Results of multivariate Cox proportional hazards regression analysis of risk factors in relation to platelet engraftment (platelet count > 50 × 109/L)
| Factor . | RR . | 95% CI . | P value . | Favorable characteristic . |
|---|---|---|---|---|
| HLA-A and HLA-B match | 1.31 | 1.17-1.47 | .0001 | Match |
| DRBI match5-150 | 1.55 | 1.34-1.78 | .0001 | Match |
| Recipient CMV serologic status | 0.88 | 0.81-0.95 | .0009 | Negative |
| Donor sex | 0.92 | 0.85-0.99 | .03 | Male |
| Cell dose (per 108/kg) | 1.12 | 1.10-1.15 | .0001 | Higher dose |
| Factor . | RR . | 95% CI . | P value . | Favorable characteristic . |
|---|---|---|---|---|
| HLA-A and HLA-B match | 1.31 | 1.17-1.47 | .0001 | Match |
| DRBI match5-150 | 1.55 | 1.34-1.78 | .0001 | Match |
| Recipient CMV serologic status | 0.88 | 0.81-0.95 | .0009 | Negative |
| Donor sex | 0.92 | 0.85-0.99 | .03 | Male |
| Cell dose (per 108/kg) | 1.12 | 1.10-1.15 | .0001 | Higher dose |
RR indicates relative risk; CI, confidence interval; CMV, cytomegalovirus.
Includes potential DRB1 match.